10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-004319`
Period End Date	20201231
Filing Date	20210204
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	arwr-10q_20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 31 Cash Flow Statement 43 Stockholders Equity 18

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$143.58M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	103.19M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$139.92M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.38M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	102.38M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$9.00M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$845.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	103.19M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$7.07M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.25M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.32M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.78M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$86.01M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$85.02M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$79.39M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$86.89M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$323.72M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$322.37M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$33.73M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$30.88M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$15.36M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$14.94M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$137.49M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$110.86M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$16.14M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.75M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$265.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$265.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$499.25M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$522.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.83M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.83M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.57M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.39M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$8.06M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$2.75M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.09M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.18M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$6.74M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$19.29M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$17.00K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$40.68M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$25.09M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$19.68M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$20.04M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$19.68M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$20.04M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000 shares authorized; 103,194 and 102,376 shares issued and outstanding as of December 31, 2020 and September 30, 2020, respectively	`CommonStockValue`	$195.00K	USD	Point-in-time
Common stock, $0.001 par value; 145,000 shares authorized; 103,194 and 102,376 shares issued and outstanding as of December 31, 2020 and September 30, 2020, respectively	`CommonStockValue`	$195.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$978.65M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$965.41M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$198.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$18.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-503.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-524.58M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.47M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.03M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$461.78M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$499.25M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$522.50M	USD	Point-in-time

Income Statement 31 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$29.45M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$21.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$23.37M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$36.55M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.80M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.93M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$34.31M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$45.36M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-4.85M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-24.05M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.17M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.18M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.15M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.18M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$3.32M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-20.73M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.67M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-20.73M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-2.67M	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.03	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.20	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.20	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.03	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	102.76M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	97.09M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.76M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.09M	shares	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$196.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$180.00K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-2.48M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-20.55M	USD	1 Quarter

Cash Flow Statement 43 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-20.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-2.67M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$4.49M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$8.14M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.26M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.85M	USD	1 Quarter
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-177.00K	USD	1 Quarter
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$302.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$8.16M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$684.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.38M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.19M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-28.77M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-12.55M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.00M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.55M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.21M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.13M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-855.00K	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$953.00K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-38.92M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-23.53M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.27M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.32M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$34.43M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$13.60M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$30.16M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$9.28M	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$3.00M	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$5.10M	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.48M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$253.48M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$5.10M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.66M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$239.23M	USD	1 Quarter
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$461.03M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.92M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$143.58M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$461.03M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.92M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$143.58M	USD	Point-in-time

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.47M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.03M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$461.78M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$8.14M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.49M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.10M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00M	USD	1 Quarter
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	537,612.00	shares	1 Quarter
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$250.48M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$196.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$180.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-20.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-2.67M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.47M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.03M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$461.78M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.